25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Applied Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Applied Therapeutics Inc together

I guess you are interested in Applied Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Applied Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Applied Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Applied Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.2%

What is your share worth?

Current worth
$0.05
Expected worth in 1 year
$0.20
How sure are you?
29.2%

+ What do you gain per year?

Total Gains per Share
$0.15
Return On Investment
22.5%

For what price can you sell your share?

Current Price per Share
$0.65
Expected price per share
$0 - $0.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Applied Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.65
Intrinsic Value Per Share
$-7.92 - $-9.26
Total Value Per Share
$-7.87 - $-9.21

2.2. Growth of Applied Therapeutics Inc (5 min.)




Is Applied Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$5.8m-$3.8m$35.9m112.0%

How much money is Applied Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$46.8m-$21.7m-$25m-53.5%
Net Profit Margin-23,184.6%-22.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Applied Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#667 / 925

Most Revenue
#908 / 925

Most Profit
#805 / 925

Most Efficient
#882 / 925
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Applied Therapeutics Inc?

Welcome investor! Applied Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Applied Therapeutics Inc.

First you should know what it really means to hold a share of Applied Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied Therapeutics Inc is $0.647. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.05. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.59-91.1%-0.40-62.2%-0.24-37.1%-0.25-38.8%-0.22-34.3%
Usd Book Value Change Per Share-0.57-88.3%0.045.6%-0.04-6.9%-0.01-1.7%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.57-88.3%0.045.6%-0.04-6.9%-0.01-1.6%0.000.3%
Usd Price Per Share8.50-5.83-1.34-11.83-10.66-
Price to Earnings Ratio-3.60-9.58--1.51--12.60--12.93-
Price-to-Total Gains Ratio-14.87-9.30--159.78-27.60-19.45-
Price to Book Ratio167.86-41.10--15.50-20.46-19.78-
Price-to-Total Gains Ratio-14.87-9.30--159.78-27.60-19.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.647
Number of shares1545
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.04-0.01
Usd Total Gains Per Share0.04-0.01
Gains per Quarter (1545 shares)56.22-16.48
Gains per Year (1545 shares)224.88-65.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102252150-66-76
204504400-132-142
306756650-198-208
409008900-264-274
50112411151-330-340
60134913401-396-406
70157415651-462-472
80179917901-528-538
90202420151-594-604
100224922401-660-670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.023.00.04.2%1.023.00.04.2%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%7.017.00.029.2%7.017.00.029.2%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.023.04.2%1.00.023.04.2%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%7.017.00.029.2%7.017.00.029.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Applied Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.5720.036-1671%-0.044-92%-0.011-98%0.002-27188%
Book Value Per Share--0.0510.276-82%-0.033+165%0.469-89%0.412-88%
Current Ratio--1.0571.481-29%0.925+14%3.860-73%4.042-74%
Debt To Asset Ratio--0.9450.811+16%1.093-14%0.564+68%0.603+57%
Debt To Equity Ratio--17.0874.775+258%2.112+709%1.869+814%1.585+978%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Enterprise Value--987219000.000704722230.000+40%143857599.000+586%1422665657.200-31%1397798728.364-29%
Eps---0.589-0.402-32%-0.240-59%-0.251-57%-0.222-62%
Ev To Ebitda Ratio---8.327-7.571-9%-3.787-55%-17.009+104%-18.180+118%
Ev To Sales Ratio--2022.9901016.976+99%infnan%infnan%infnan%
Free Cash Flow Per Share---0.201-0.176-12%-0.116-42%-0.163-19%-0.147-27%
Free Cash Flow To Equity Per Share---0.2010.132-252%-0.021-89%0.028-808%0.034-687%
Gross Profit Margin--1.0000.989+1%1.0000%0.998+0%0.998+0%
Intrinsic Value_10Y_max---9.257--------
Intrinsic Value_10Y_min---7.918--------
Intrinsic Value_1Y_max---0.687--------
Intrinsic Value_1Y_min---0.674--------
Intrinsic Value_3Y_max---2.247--------
Intrinsic Value_3Y_min---2.141--------
Intrinsic Value_5Y_max---4.028--------
Intrinsic Value_5Y_min---3.723--------
Market Cap75282332.000-1214%989026000.000678355480.000+46%155364349.000+537%1376631107.200-28%1240422834.333-20%
Net Profit Margin---562.221-231.846-59%-0.221-100%-46.413-92%-38.678-93%
Operating Margin---243.795-116.680-52%-0.255-100%-23.387-90%-19.489-92%
Operating Ratio--244.795101.516+141%0.507+48153%20.405+1100%17.004+1340%
Pb Ratio12.777-1214%167.85941.097+308%-15.499+109%20.455+721%19.778+749%
Pe Ratio-0.274+92%-3.6059.582-138%-1.511-58%-12.601+250%-12.928+259%
Price Per Share0.647-1214%8.5005.830+46%1.335+537%11.831-28%10.661-20%
Price To Free Cash Flow Ratio-0.807+92%-10.598-8.200-23%-2.987-72%-18.817+78%-18.483+74%
Price To Total Gains Ratio-1.132+92%-14.8739.301-260%-159.780+974%27.601-154%19.455-176%
Quick Ratio--1.0021.418-29%0.870+15%4.835-79%4.892-80%
Return On Assets---0.644-0.466-28%-0.520-19%-0.352-45%-0.348-46%
Return On Equity---11.641-3.212-72%-0.358-97%-1.035-91%-0.903-92%
Total Gains Per Share---0.5720.036-1671%-0.044-92%-0.011-98%0.002-27009%
Usd Book Value--5892000.00032108000.000-82%-3847250.000+165%54543100.000-89%47896416.667-88%
Usd Book Value Change Per Share---0.5720.036-1671%-0.044-92%-0.011-98%0.002-27188%
Usd Book Value Per Share--0.0510.276-82%-0.033+165%0.469-89%0.412-88%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Enterprise Value--987219000.000704722230.000+40%143857599.000+586%1422665657.200-31%1397798728.364-29%
Usd Eps---0.589-0.402-32%-0.240-59%-0.251-57%-0.222-62%
Usd Free Cash Flow---23330000.000-20460250.000-12%-13515250.000-42%-18972300.000-19%-17050625.000-27%
Usd Free Cash Flow Per Share---0.201-0.176-12%-0.116-42%-0.163-19%-0.147-27%
Usd Free Cash Flow To Equity Per Share---0.2010.132-252%-0.021-89%0.028-808%0.034-687%
Usd Market Cap75282332.000-1214%989026000.000678355480.000+46%155364349.000+537%1376631107.200-28%1240422834.333-20%
Usd Price Per Share0.647-1214%8.5005.830+46%1.335+537%11.831-28%10.661-20%
Usd Profit---68591000.000-46827500.000-32%-21795250.000-68%-28393700.000-59%-25103041.667-63%
Usd Revenue--122000.000-52750.000+143%2665000.000-95%522450.000-77%435375.000-72%
Usd Total Gains Per Share---0.5720.036-1671%-0.044-92%-0.011-98%0.002-27009%
 EOD+3 -5MRQTTM+10 -28YOY+14 -225Y+3 -3610Y+3 -36

3.3 Fundamental Score

Let's check the fundamental score of Applied Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.274
Price to Book Ratio (EOD)Between0-112.777
Net Profit Margin (MRQ)Greater than0-562.221
Operating Margin (MRQ)Greater than0-243.795
Quick Ratio (MRQ)Greater than11.002
Current Ratio (MRQ)Greater than11.057
Debt to Asset Ratio (MRQ)Less than10.945
Debt to Equity Ratio (MRQ)Less than117.087
Return on Equity (MRQ)Greater than0.15-11.641
Return on Assets (MRQ)Greater than0.05-0.644
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.669
Ma 20Greater thanMa 500.599
Ma 50Greater thanMa 1000.830
Ma 100Greater thanMa 2004.700
OpenGreater thanClose0.591
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-02-06 11:15:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Applied Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -56,222.1% means that $-562.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied Therapeutics Inc:

  • The MRQ is -56,222.1%. The company is making a huge loss. -2
  • The TTM is -23,184.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56,222.1%TTM-23,184.6%-33,037.5%
TTM-23,184.6%YOY-22.1%-23,162.5%
TTM-23,184.6%5Y-4,641.3%-18,543.3%
5Y-4,641.3%10Y-3,867.8%-773.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-56,222.1%-100.3%-56,121.8%
TTM-23,184.6%-211.5%-22,973.1%
YOY-22.1%-213.8%+191.7%
5Y-4,641.3%-346.2%-4,295.1%
10Y-3,867.8%-489.2%-3,378.6%
4.3.1.2. Return on Assets

Shows how efficient Applied Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • -64.4% Return on Assets means that Applied Therapeutics Inc generated $-0.64 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied Therapeutics Inc:

  • The MRQ is -64.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -46.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-64.4%TTM-46.6%-17.8%
TTM-46.6%YOY-52.0%+5.4%
TTM-46.6%5Y-35.2%-11.3%
5Y-35.2%10Y-34.8%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.4%-12.0%-52.4%
TTM-46.6%-12.1%-34.5%
YOY-52.0%-11.4%-40.6%
5Y-35.2%-12.8%-22.4%
10Y-34.8%-14.6%-20.2%
4.3.1.3. Return on Equity

Shows how efficient Applied Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • -1,164.1% Return on Equity means Applied Therapeutics Inc generated $-11.64 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied Therapeutics Inc:

  • The MRQ is -1,164.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -321.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,164.1%TTM-321.2%-842.9%
TTM-321.2%YOY-35.8%-285.4%
TTM-321.2%5Y-103.5%-217.7%
5Y-103.5%10Y-90.3%-13.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,164.1%-15.4%-1,148.7%
TTM-321.2%-16.2%-305.0%
YOY-35.8%-14.7%-21.1%
5Y-103.5%-18.6%-84.9%
10Y-90.3%-19.5%-70.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Applied Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Applied Therapeutics Inc is operating .

  • Measures how much profit Applied Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -24,379.5% means the company generated $-243.80  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied Therapeutics Inc:

  • The MRQ is -24,379.5%. The company is operating very inefficient. -2
  • The TTM is -11,668.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24,379.5%TTM-11,668.0%-12,711.5%
TTM-11,668.0%YOY-25.5%-11,642.5%
TTM-11,668.0%5Y-2,338.7%-9,329.3%
5Y-2,338.7%10Y-1,948.9%-389.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24,379.5%-201.5%-24,178.0%
TTM-11,668.0%-313.4%-11,354.6%
YOY-25.5%-215.2%+189.7%
5Y-2,338.7%-371.8%-1,966.9%
10Y-1,948.9%-492.1%-1,456.8%
4.3.2.2. Operating Ratio

Measures how efficient Applied Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 244.80 means that the operating costs are $244.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 244.795. The company is inefficient in keeping operating costs low. -1
  • The TTM is 101.516. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ244.795TTM101.516+143.279
TTM101.516YOY0.507+101.009
TTM101.5165Y20.405+81.112
5Y20.40510Y17.004+3.401
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ244.7952.139+242.656
TTM101.5163.198+98.318
YOY0.5073.358-2.851
5Y20.4054.842+15.563
10Y17.0046.500+10.504
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Applied Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.06 means the company has $1.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 1.057. The company is just able to pay all its short-term debts.
  • The TTM is 1.481. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.057TTM1.481-0.424
TTM1.481YOY0.925+0.556
TTM1.4815Y3.860-2.379
5Y3.86010Y4.042-0.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0573.610-2.553
TTM1.4813.871-2.390
YOY0.9254.609-3.684
5Y3.8605.977-2.117
10Y4.0426.216-2.174
4.4.3.2. Quick Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.418. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.002TTM1.418-0.416
TTM1.418YOY0.870+0.548
TTM1.4185Y4.835-3.417
5Y4.83510Y4.892-0.058
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0023.085-2.083
TTM1.4183.360-1.942
YOY0.8704.400-3.530
5Y4.8355.972-1.137
10Y4.8926.483-1.591
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Applied Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Applied Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Applied Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.94 means that Applied Therapeutics Inc assets are financed with 94.5% credit (debt) and the remaining percentage (100% - 94.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.945. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.811. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.945TTM0.811+0.133
TTM0.811YOY1.093-0.282
TTM0.8115Y0.564+0.248
5Y0.56410Y0.603-0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9450.341+0.604
TTM0.8110.343+0.468
YOY1.0930.315+0.778
5Y0.5640.363+0.201
10Y0.6030.384+0.219
4.5.4.2. Debt to Equity Ratio

Measures if Applied Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 1,708.7% means that company has $17.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 17.087. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.775. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ17.087TTM4.775+12.312
TTM4.775YOY2.112+2.663
TTM4.7755Y1.869+2.906
5Y1.86910Y1.585+0.284
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.0870.386+16.701
TTM4.7750.429+4.346
YOY2.1120.391+1.721
5Y1.8690.450+1.419
10Y1.5850.495+1.090
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Applied Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.60 means the investor is paying $-3.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied Therapeutics Inc:

  • The EOD is -0.274. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.605. Based on the earnings, the company is expensive. -2
  • The TTM is 9.582. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-0.274MRQ-3.605+3.330
MRQ-3.605TTM9.582-13.187
TTM9.582YOY-1.511+11.093
TTM9.5825Y-12.601+22.183
5Y-12.60110Y-12.928+0.327
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.274-2.247+1.973
MRQ-3.605-2.706-0.899
TTM9.582-3.253+12.835
YOY-1.511-3.392+1.881
5Y-12.601-6.132-6.469
10Y-12.928-6.735-6.193
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied Therapeutics Inc:

  • The EOD is -0.807. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.598. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.200. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.807MRQ-10.598+9.792
MRQ-10.598TTM-8.200-2.398
TTM-8.200YOY-2.987-5.213
TTM-8.2005Y-18.817+10.617
5Y-18.81710Y-18.483-0.335
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.807-3.026+2.219
MRQ-10.598-3.582-7.016
TTM-8.200-3.816-4.384
YOY-2.987-4.463+1.476
5Y-18.817-8.265-10.552
10Y-18.483-9.266-9.217
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Applied Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 167.86 means the investor is paying $167.86 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied Therapeutics Inc:

  • The EOD is 12.777. Based on the equity, the company is expensive. -2
  • The MRQ is 167.859. Based on the equity, the company is expensive. -2
  • The TTM is 41.097. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.777MRQ167.859-155.082
MRQ167.859TTM41.097+126.762
TTM41.097YOY-15.499+56.596
TTM41.0975Y20.455+20.642
5Y20.45510Y19.778+0.678
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.7771.948+10.829
MRQ167.8592.223+165.636
TTM41.0972.427+38.670
YOY-15.4992.469-17.968
5Y20.4553.767+16.688
10Y19.7784.507+15.271
4.6.2. Total Gains per Share

2.4. Latest News of Applied Therapeutics Inc

Does Applied Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Applied Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-16
13:18
APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)Read
2025-02-15
05:18
APLT 截止日期通知:享譽全球的律師事務所 ROSEN 鼓勵 Applied Therapeutics, Inc. 投資者在對 APLT 提出證券集體訴訟的重要截止日期 2 月 18 日前聘請律師Read
2025-02-14
22:21
APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTRead
2025-02-14
16:45
APLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action LawsuitRead
2025-02-14
14:37
APLT SHAREHOLDER ACTION: Applied Therapeutics 80% Stock Drop Prompts Class Action; Contact BFA Law by February 18 if You Suffered Losses (NASDAQ:APLT)Read
2025-02-13
21:51
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion.Read
2025-02-13
18:45
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineRead
2025-02-13
15:31
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTRead
2025-02-12
18:52
APLT LAWSUIT ALERT: The Gross Law Firm Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineRead
2025-02-12
15:41
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied TherapeuticsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied Therapeutics Inc.

4.8.1. Institutions holding Applied Therapeutics Inc

Institutions are holding 102.047% of the shares of Applied Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30HHG PLC9.05970.045910541528289332337.8301
2024-09-30Morgan Stanley - Brokerage Accounts8.51220.00619904530286505640.6999
2024-09-30VR Adviser, LLC8.44394.374198250002821292.9564
2024-09-30Perceptive Advisors LLC6.87971.4395800500000
2024-09-30BlackRock Inc5.96670.001269426993729125.6762
2024-09-30Franklin Resources Inc5.84490.0176800910-3412035-33.4089
2024-09-30Propel Bio Management LLC5.644632.3801656785800
2024-09-30Knoll Capital Management LP4.79121.9578557468700
2024-09-30Vanguard Group Inc4.50590.00085242949-79511-1.4939
2024-09-30Deutsche Bank AG3.81380.01544437602209411989.3593
2024-09-30Adage Capital Partners Gp LLC3.53430.06174112361133757748.2047
2024-09-30State Street Corp3.17520.001336946072038724123.1201
2024-09-30Simplify Asset Management Inc.2.42141.1157281750500
2024-09-30TANG CAPITAL MANAGEMENT LLC2.34621.6577273000040000017.1674
2024-09-30Geode Capital Management, LLC1.79760.00142091669-7146-0.3405
2024-09-30Rock Springs Capital Management LP1.50090.483174644919144512.3115
2024-09-30Siren, L.L.C.1.40410.6942163376816337680
2024-09-30StemPoint Capital LP1.33613.95611554586-656734-29.6987
2024-09-30Opaleye Management Inc1.13441.87141320000-360000-21.4286
2024-09-30Vestal Point Capital LP0.9840.73811145000-4285000-78.9134
Total 83.096670.818596688708+5308627+5.5%

4.9.2. Funds holding Applied Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31T. Rowe Price Small-Cap Value2.90890.027633846663001100782.4208
2024-12-31Vanguard Total Stock Mkt Idx Inv2.6680.0002310443500
2024-12-31Simplify Propel Opportunities ETF2.42145.7325281750500
2025-01-29iShares Russell 2000 ETF2.26220.00192632187-399-0.0152
2024-12-31T. Rowe Price U.S. SC Value Eq Tr-Z1.61910.0275188388118131812564.6124
2024-11-30Janus Henderson Global Life Sciences D1.38870.062816158141300753412.8575
2024-12-31Franklin Biotechnology Discv A(acc)USD1.08550.0782126304800
2024-12-31Vanguard Institutional Extnd Mkt Idx Tr1.08370.00112609382480.0197
2024-11-30Fidelity Small Cap Index0.8390.0067976288-6045-0.6154
2024-12-31Franklin Biotechnology Discovery A0.63610.079774020000
2024-12-31Xtrackers S&P 500 Swap ETF 1C0.53480.00562222700
2024-12-31State St Russell Sm/Mid Cp® Indx NL Cl C0.5250.0012610894-8500-1.3723
2025-01-29iShares Biotechnology ETF0.47010.004654694728950.5321
2025-01-29iShares Russell 2000 Growth ETF0.45180.002352568900
2024-12-31HBM Healthcare Investments AG Ord0.42970.022950000017836655.4562
2024-12-31Fidelity Extended Market Index0.4020.001467751-3768-0.7991
2024-12-31Vanguard Russell 2000 ETF0.39530.00345994774161.6388
2025-01-30Schwab US Small-Cap ETF™0.35810.0012416622-522-0.1251
2025-01-29iShares Russell 2000 Value ETF0.29810.001634690600
2024-12-31State St Russell Sm Cap® Indx SL Cl I0.29210.003133990000
Total 21.06966.06424515845+6284725+25.6%

5.3. Insider Transactions

Insiders are holding 5.797% of the shares of Applied Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-08-14Shoshana ShendelmanSELL1195915.93
2024-08-12Shoshana ShendelmanSELL3000005.98
2024-06-06Leslie D FuntleyderSELL169804.32
2024-06-06Riccardo PerfettiSELL220034.32
2024-06-06Shoshana ShendelmanSELL617954.32
2024-06-04Real Estate Equitie AlexandriaSELL1500004.21
2024-03-14Leslie D FuntleyderSELL287275.39
2024-03-14Riccardo PerfettiSELL1108045.39
2024-03-14Shoshana ShendelmanSELL3185735.39
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets106,566
Total Liabilities100,674
Total Stockholder Equity5,892
 As reported
Total Liabilities 100,674
Total Stockholder Equity+ 5,892
Total Assets = 106,566

Assets

Total Assets106,566
Total Current Assets104,603
Long-term Assets1,963
Total Current Assets
Cash And Cash Equivalents 98,867
Net Receivables 262
Other Current Assets 5,736
Total Current Assets  (as reported)104,603
Total Current Assets  (calculated)104,865
+/- 262
Long-term Assets
Property Plant Equipment 1,963
Long-term Assets  (as reported)1,963
Long-term Assets  (calculated)1,963
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities98,967
Long-term Liabilities1,707
Total Stockholder Equity5,892
Total Current Liabilities
Short-term Debt 264
Accounts payable 2,837
Other Current Liabilities 95,866
Total Current Liabilities  (as reported)98,967
Total Current Liabilities  (calculated)98,967
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,707
Long-term Liabilities  (as reported)1,707
Long-term Liabilities  (calculated)1,707
+/-0
Total Stockholder Equity
Common Stock11
Retained Earnings -618,217
Other Stockholders Equity 624,098
Total Stockholder Equity (as reported)5,892
Total Stockholder Equity (calculated)5,892
+/-0
Other
Capital Stock11
Cash and Short Term Investments 98,867
Common Stock Shares Outstanding 14,435
Liabilities and Stockholders Equity 106,566
Net Debt -96,896
Net Invested Capital 5,892
Net Working Capital 5,636
Property Plant and Equipment Gross 1,963
Short Long Term Debt Total 1,971



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
20,246
16,872
46,784
37,264
48,389
165,882
150,572
124,838
104,506
156,219
136,959
118,547
89,892
64,953
78,178
56,679
38,363
30,004
43,646
45,195
54,833
151,234
127,778
106,566
106,566127,778151,23454,83345,19543,64630,00438,36356,67978,17864,95389,892118,547136,959156,219104,506124,838150,572165,88248,38937,26446,78416,87220,246000
   > Total Current Assets 
0
0
0
20,246
16,872
46,784
37,034
46,155
163,741
148,524
122,885
102,593
154,406
135,250
116,943
88,394
63,564
76,898
55,510
37,308
29,063
42,821
44,488
54,386
150,906
127,572
104,603
104,603127,572150,90654,38644,48842,82129,06337,30855,51076,89863,56488,394116,943135,250154,406102,593122,885148,524163,74146,15537,03446,78416,87220,246000
       Cash And Cash Equivalents 
0
0
0
18,748
14,686
41,076
13,065
18,850
92,503
100,854
48,679
57,466
84,067
78,434
70,207
53,888
38,214
55,728
40,388
16,657
22,917
35,616
37,457
49,898
146,484
122,197
98,867
98,867122,197146,48449,89837,45735,61622,91716,65740,38855,72838,21453,88870,20778,43484,06757,46648,679100,85492,50318,85013,06541,07614,68618,748000
       Short-term Investments 
0
0
0
0
0
0
19,889
20,004
61,806
37,644
67,826
39,363
63,992
47,182
38,595
26,935
17,437
11,994
6,990
13,923
0
0
0
0
253
0
0
00253000013,9236,99011,99417,43726,93538,59547,18263,99239,36367,82637,64461,80620,00419,889000000
       Net Receivables 
0
0
0
0
0
0
0
0
136
33
37
505
591
335
327
525
492
288
276
275
285
285
285
285
262
262
262
262262262285285285285275276288492525327335591505373313600000000
       Other Current Assets 
0
0
0
1,498
2,186
5,708
525
91
131
440
522
280
213
500
473
471
7,421
8,888
8,132
1,131
6,146
536
1,792
920
4,160
5,113
5,736
5,7365,1134,1609201,7925366,1461,1318,1328,8887,421471473500213280522440131915255,7082,1861,498000
   > Long-term Assets 
0
0
0
0
0
0
230
2,234
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
328
206
1,963
1,9632063284477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,234230000000
       Property Plant Equipment 
0
0
0
0
0
0
0
2,035
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
328
206
1,963
1,9632063284477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,0350000000
       Long Term Investments 
0
0
0
0
0
0
0
199
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001990000000
       Other Assets 
0
0
0
0
0
0
230
199
199
199
199
1,913
201
201
200
200
199
199
199
0
0
197
0
0
0
0
0
00000197001991991992002002012011,913199199199199230000000
> Total Liabilities 
0
0
0
4,428
44,789
6,780
6,517
15,782
10,054
20,368
21,898
22,567
20,998
24,519
31,846
27,353
22,990
52,370
47,050
34,302
34,076
47,980
56,239
71,979
83,940
55,386
100,674
100,67455,38683,94071,97956,23947,98034,07634,30247,05052,37022,99027,35331,84624,51920,99822,56721,89820,36810,05415,7826,5176,78044,7894,428000
   > Total Current Liabilities 
0
0
0
4,428
6,328
6,780
6,517
14,099
8,466
18,876
20,502
21,235
19,774
23,405
30,843
26,462
22,217
51,715
46,514
33,424
33,251
47,188
55,504
71,182
83,905
55,356
98,967
98,96755,35683,90571,18255,50447,18833,25133,42446,51451,71522,21726,46230,84323,40519,77421,23520,50218,8768,46614,0996,5176,7806,3284,428000
       Short-term Debt 
0
0
0
0
0
0
0
356
364
3,594
2,528
1,480
415
3,584
2,410
1,231
453
462
2,024
1,099
483
1,726
1,266
739
308
370
264
2643703087391,2661,7264831,0992,0244624531,2312,4103,5844151,4802,5283,5943643560000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
3,222
2,148
1,074
0
3,158
1,974
789
0
2,487
1,554
622
0
1,240
775
310
0
0
0
0003107751,24006221,5542,48707891,9743,15801,0742,1483,222000000000
       Accounts payable 
0
0
0
3,015
2,649
3,987
1,688
8,793
1,606
5,649
1,945
640
3,475
3,310
9,170
9,461
5,922
8,691
6,973
4,534
5,555
4,687
6,005
1,742
4,019
2,683
2,837
2,8372,6834,0191,7426,0054,6875,5554,5346,9738,6915,9229,4619,1703,3103,4756401,9455,6491,6068,7931,6883,9872,6493,015000
       Other Current Liabilities 
0
0
0
1,413
3,679
2,793
4,829
264
447
783
770
553
522
576
657
987
15,842
42,562
37,517
27,791
27,213
26,453
37,167
68,034
79,101
51,970
95,866
95,86651,97079,10168,03437,16726,45327,21327,79137,51742,56215,8429876575765225537707834472644,8292,7933,6791,413000
   > Long-term Liabilities 
0
0
0
0
38,461
38,461
0
1,683
1,588
1,492
1,396
1,332
1,224
1,114
1,003
891
773
655
536
878
825
792
735
797
35
30
1,707
1,70730357977357928258785366557738911,0031,1141,2241,3321,3961,4921,5881,683038,46138,4610000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
622
0
0
0
0
0
00000622000000000000000000000
> Total Stockholder Equity
-3,961
0
0
15,818
-27,917
40,004
30,747
32,607
155,828
130,204
102,940
81,939
135,221
112,440
86,701
62,539
41,963
25,808
9,629
4,061
-4,072
-4,334
-11,044
-17,146
67,294
72,392
5,892
5,89272,39267,294-17,146-11,044-4,334-4,0724,0619,62925,80841,96362,53986,701112,440135,22181,939102,940130,204155,82832,60730,74740,004-27,91715,81800-3,961
   Common Stock
0
0
0
0
0
1
1
1
2
2
2
2
3
3
3
3
3
5
5
5
5
6
7
8
11
11
11
111111876555533333222211100000
   Retained Earnings Total Equity00000-388,537-358,96000000-239,156-210,738-184,910-160,73100000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-46,784
11
-2
89
-29
-94
-112
-154
-185
-254
-107
-80
6
23
51
0
0
0
0
0
0
0
000000051236-80-107-254-185-154-112-94-2989-211-46,78400000
   Capital Surplus 
0
0
0
0
2,070
78,427
79,872
99,378
234,876
0
0
242,780
320,282
323,360
326,108
0
0
0
0
0
354,883
384,197
0
0
0
0
0
00000384,197354,88300000326,108323,360320,282242,78000234,87699,37879,87278,4272,0700000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
0
0
0
37,075
-4,184
78,427
42,608
99,378
234,876
237,429
240,074
242,780
320,282
323,360
326,108
328,958
331,476
341,090
343,995
352,828
354,883
384,197
419,856
451,432
619,807
622,007
624,098
624,098622,007619,807451,432419,856384,197354,883352,828343,995341,090331,476328,958326,108323,360320,282242,780240,074237,429234,87699,37842,60878,427-4,18437,075000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,993
Cost of Revenue-353
Gross Profit9,6409,640
 
Operating Income (+$)
Gross Profit9,640
Operating Expense-74,528
Operating Income-64,535-64,888
 
Operating Expense (+$)
Research Development53,905
Selling General Administrative20,623
Selling And Marketing Expenses353
Operating Expense74,52874,881
 
Net Interest Income (+$)
Interest Income1,372
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,372
 
Pretax Income (+$)
Operating Income-64,535
Net Interest Income1,372
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-119,763-9,307
EBIT - interestExpense = -64,535
-119,578
-119,763
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-64,535-119,763
Earnings Before Interest and Taxes (EBITDA)-64,534
 
After tax Income (+$)
Income Before Tax-119,763
Tax Provision-0
Net Income From Continuing Ops-119,763-119,763
Net Income-119,763
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses74,528
Total Other Income/Expenses Net-55,228-1,372
 

Technical Analysis of Applied Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Applied Therapeutics Inc. The general trend of Applied Therapeutics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Applied Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Applied Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.75 < 0.757 < 0.76.

The bearish price targets are: .

Tweet this
Applied Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Applied Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Applied Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Applied Therapeutics Inc. The current macd is -0.20130554.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Applied Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Applied Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Applied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartApplied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Applied Therapeutics Inc. The current adx is 43.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Applied Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Applied Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Applied Therapeutics Inc. The current sar is 0.5386.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Applied Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Applied Therapeutics Inc. The current rsi is 35.67. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Applied Therapeutics Inc Daily Relative Strength Index (RSI) ChartApplied Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Applied Therapeutics Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Applied Therapeutics Inc Daily Stochastic Oscillator ChartApplied Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Applied Therapeutics Inc. The current cci is 76.68.

Applied Therapeutics Inc Daily Commodity Channel Index (CCI) ChartApplied Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Applied Therapeutics Inc. The current cmo is 5.37972141.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Applied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartApplied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Applied Therapeutics Inc. The current willr is -18.67966992.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Applied Therapeutics Inc Daily Williams %R ChartApplied Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Applied Therapeutics Inc.

Applied Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Applied Therapeutics Inc. The current atr is 0.09837452.

Applied Therapeutics Inc Daily Average True Range (ATR) ChartApplied Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Applied Therapeutics Inc. The current obv is -51,307,413.

Applied Therapeutics Inc Daily On-Balance Volume (OBV) ChartApplied Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Applied Therapeutics Inc. The current mfi is 53.70.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Applied Therapeutics Inc Daily Money Flow Index (MFI) ChartApplied Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Applied Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Applied Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.669
Ma 20Greater thanMa 500.599
Ma 50Greater thanMa 1000.830
Ma 100Greater thanMa 2004.700
OpenGreater thanClose0.591
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Applied Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Applied Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Applied Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Applied Therapeutics Inc.

Receive notifications about Applied Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.